|
AKAP13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.027800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.769800E-01 |
| Normal-vs-Stage2 |
9.615600E-01 |
| Normal-vs-Stage3 |
5.439400E-01 |
| Normal-vs-Stage4 |
4.203000E-01 |
| Stage1-vs-Stage2 |
5.858000E-01 |
| Stage1-vs-Stage3 |
9.642800E-01 |
| Stage1-vs-Stage4 |
4.994600E-01 |
| Stage2-vs-Stage3 |
6.023200E-01 |
| Stage2-vs-Stage4 |
3.537400E-01 |
| Stage3-vs-Stage4 |
5.811400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.478800E-01 |
| Normal-vs-AfricanAmerican |
6.123200E-01 |
| Normal-vs-Asian |
1.308370E-02 |
| Caucasian-vs-AfricanAmerican |
9.724800E-01 |
| Caucasian-vs-Asian |
1.779830E-01 |
| AfricanAmerican-vs-Asian |
1.541350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.956800E-01 |
| Normal-vs-Female |
2.410000E-01 |
| Male-vs-Female |
2.003600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.450800E-01 |
| Normal-vs-Extreme_Weight |
7.620100E-02 |
| Normal-vs-Obese |
4.071200E-01 |
| Normal-vs-Extreme_Obese |
5.886200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.247000E-01 |
| Normal_Weight-vs-Obese |
8.594200E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.182200E-01 |
| Extreme_Weight-vs-Obese |
1.822500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.693600E-01 |
| Obese-vs-Extreme_Obese |
1.121810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.820000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.064800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.653600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.989900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.016400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.574170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.041610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.697000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.027370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.665200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.824600E-01 |
| Normal-VS-Type2 PRCC |
3.950200E-02 |
| Normal-VS-KIRP CIMP |
6.934400E-01 |
| Normal-VS-Unclassified PRCC |
1.634630E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.290400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.123000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.131700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.467010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.779700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.543600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.440600E-03 |
| Normal-vs-N1 |
7.981800E-01 |
| Normal-vs-N2 |
7.669400E-01 |
| N0-vs-N1 |
6.312500E-02 |
| N0-vs-N2 |
4.543800E-01 |
| N1-vs-N2 |
7.704200E-01 |
|
|
